Chugai Pharmaceutical Co Stock Analysis
| CHGCY Stock | USD 21.40 0.06 0.28% |
Chugai Pharmaceutical Co is overvalued with Real Value of 19.06 and Hype Value of 21.4. The main objective of Chugai Pharmaceutical pink sheet analysis is to determine its intrinsic value, which is an estimate of what Chugai Pharmaceutical Co is worth, separate from its market price. There are two main types of Chugai Pharmaceutical's stock analysis: fundamental analysis and technical analysis.
The Chugai Pharmaceutical pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Chugai |
Chugai Pink Sheet Analysis Notes
The book value of the company was currently reported as 432.94. The company last dividend was issued on the 29th of June 2022. Chugai Pharmaceutical had 12:1 split on the 6th of July 2020. Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. CHUGAI PHARMACEUTICAL operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 7664 people.The quote for Chugai Pharmaceutical Co is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Chugai Pharmaceutical Co please contact the company at 81 3 3281 6611 or go to https://www.chugai-pharm.co.jp.Chugai Pharmaceutical Investment Alerts
| Chugai Pharmaceutical generated a negative expected return over the last 90 days |
Chugai Pharmaceutical Thematic Classifications
In addition to having Chugai Pharmaceutical pink sheet in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Cash CowsCompanies that have the ability to maintain consistent cash flow over time |
Chugai Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 44.63 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Chugai Pharmaceutical's market, we take the total number of its shares issued and multiply it by Chugai Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Chugai Profitablity
The company has Profit Margin (PM) of 0.3 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.42 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.42.Technical Drivers
As of the 18th of January 2025, Chugai Pharmaceutical shows the Standard Deviation of 2.41, risk adjusted performance of (0.04), and Mean Deviation of 1.66. Chugai Pharmaceutical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Chugai Pharmaceutical Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Chugai Pharmaceutical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Chugai Pharmaceutical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Chugai Pharmaceutical Outstanding Bonds
Chugai Pharmaceutical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Chugai Pharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Chugai bonds can be classified according to their maturity, which is the date when Chugai Pharmaceutical Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| CHUBB P 68 Corp BondUS171232AE11 | View | |
| CHUBB P 6 Corp BondUS171232AQ41 | View | |
| CHUBB P 65 Corp BondUS171232AS07 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| US171239AG12 Corp BondUS171239AG12 | View | |
| CB 285 15 DEC 51 Corp BondUS171239AH94 | View | |
| CB 305 15 DEC 61 Corp BondUS171239AJ50 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Chugai Pharmaceutical Predictive Daily Indicators
Chugai Pharmaceutical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Chugai Pharmaceutical pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Chugai Pharmaceutical Forecast Models
Chugai Pharmaceutical's time-series forecasting models are one of many Chugai Pharmaceutical's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Chugai Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Chugai Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Chugai Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Chugai shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Chugai Pharmaceutical. By using and applying Chugai Pink Sheet analysis, traders can create a robust methodology for identifying Chugai entry and exit points for their positions.
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. CHUGAI PHARMACEUTICAL operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 7664 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Chugai Pharmaceutical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
Additional Tools for Chugai Pink Sheet Analysis
When running Chugai Pharmaceutical's price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.